Jie Zhou

6.3k citations
104 papers · 5.0k indexed · h-index 42
    • Cancer, Hypoxia, and Metabolism 33
    • Cancer, Lipids, and Metabolism 7
    • Eicosanoids and Hypertension Pharmacology 6
    • Cancer-related gene regulation 7
    • Epigenetics and DNA Methylation 7
    • RNA modifications and cancer 6
  • Oncology top 5%
    • Cancer-related Molecular Pathways 6
    • Nitric Oxide and Endothelin Effects 7

Jie Zhou

102 papers receiving 5.0k citations

Peers

Jie Zhou
Comparison fields: 5 of 134
  • Cancer Research 2.2k
  • Biochemistry 377
  • Molecular Biology 2.9k
  • Cell Biology 485
  • Oncology 784
Replace Kyle D. Mansfield with:
Kyle D. Mansfield United States
William Kim United States
Guy Eelen Belgium
Nobuhito Goda Japan
Weibo Luo United States
Bart Ghesquière Belgium
Julián Aragonés Spain
Weiwei Yang China
Giovanni Melillo United States
Thomas Boettger Germany
Jie Zhou relative to Kyle D. Mansfield United States Kyle D. Mansfield's profile →
Citations per field
00.5×1.5×1.9×
Kyle D. Mansfield · 1×
Citations per year

Countries citing papers authored by Jie Zhou

Since Specialization
Citations

This map shows the geographic impact of Jie Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Zhou more than expected).

Fields of papers citing papers by Jie Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Zhou. The network helps show where Jie Zhou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jie Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jie Zhou Line = papers co-authored together Jie Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20254
3 20232
4 20230
5 20232
6 20233
7 20228
8 202229
9 20207
10 201496
11 201364
12 201349
13 201262
14 20117
15 201131
16 2010352
17 200942
18 20091
19 200951
20 200732

About Jie Zhou

Jie Zhou is a scholar working on Cancer Research, Biochemistry and Molecular Biology, having authored 104 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (33 papers), Nitric Oxide and Endothelin Effects (7 papers), Cancer-related gene regulation (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer, Lipids, and Metabolism (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Cancer-related Molecular Pathways (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (2.2k citations), Biochemistry (377 citations) and Molecular Biology (2.9k citations). Jie Zhou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Bernhard Brüne, Tobias Schmid, Richard G. Pestell, Joachim Fandrey, Michael P. Lisanti, Roman Köhl, Eric Metzen, Wolfgang Jelkmann, Chenguang Wang and Ronald Frank.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026